OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Chromatin reprogramming as an adaptation mechanism in advanced prostate cancer
Peder R. Braadland, Alfonso Urbanucci
Endocrine Related Cancer (2019) Vol. 26, Iss. 4, pp. R211-R235
Open Access | Times Cited: 20
Peder R. Braadland, Alfonso Urbanucci
Endocrine Related Cancer (2019) Vol. 26, Iss. 4, pp. R211-R235
Open Access | Times Cited: 20
Showing 20 citing articles:
Interaction of an abiraterone with calf thymus DNA: Investigation with spectroscopic technique and modelling studies
Tanveer A. Wani, Nawaf A. Alsaif, Ahmed H. Bakheit, et al.
Bioorganic Chemistry (2020) Vol. 100, pp. 103957-103957
Open Access | Times Cited: 83
Tanveer A. Wani, Nawaf A. Alsaif, Ahmed H. Bakheit, et al.
Bioorganic Chemistry (2020) Vol. 100, pp. 103957-103957
Open Access | Times Cited: 83
BRD9 Is a Critical Regulator of Androgen Receptor Signaling and Prostate Cancer Progression
Aktan Alpsoy, Sagar M. Utturkar, Benjamin C. Carter, et al.
Cancer Research (2020) Vol. 81, Iss. 4, pp. 820-833
Open Access | Times Cited: 60
Aktan Alpsoy, Sagar M. Utturkar, Benjamin C. Carter, et al.
Cancer Research (2020) Vol. 81, Iss. 4, pp. 820-833
Open Access | Times Cited: 60
A Comprehensive Review of BET Protein Biochemistry, Physiology, and Pathological Roles
Hafiz Akbar Ali, Yalan Li, Akram Hafiz Muhammad Bilal, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 32
Hafiz Akbar Ali, Yalan Li, Akram Hafiz Muhammad Bilal, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 32
Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer
Hilal Saraç, Tunç Morova, Elisabete Pires, et al.
Oncogene (2019) Vol. 39, Iss. 10, pp. 2187-2201
Open Access | Times Cited: 37
Hilal Saraç, Tunç Morova, Elisabete Pires, et al.
Oncogene (2019) Vol. 39, Iss. 10, pp. 2187-2201
Open Access | Times Cited: 37
Protein Arginine Methyltransferase 5 Promotes pICln-Dependent Androgen Receptor Transcription in Castration-Resistant Prostate Cancer
Elena Beketova, Shuyi Fang, Jake L. Owens, et al.
Cancer Research (2020) Vol. 80, Iss. 22, pp. 4904-4917
Open Access | Times Cited: 29
Elena Beketova, Shuyi Fang, Jake L. Owens, et al.
Cancer Research (2020) Vol. 80, Iss. 22, pp. 4904-4917
Open Access | Times Cited: 29
ACK1–AR and AR–HOXB13 signaling axes: epigenetic regulation of lethal prostate cancers
Eric H. Kim, Dengfeng Cao, Nupam P. Mahajan, et al.
NAR Cancer (2020) Vol. 2, Iss. 3
Open Access | Times Cited: 28
Eric H. Kim, Dengfeng Cao, Nupam P. Mahajan, et al.
NAR Cancer (2020) Vol. 2, Iss. 3
Open Access | Times Cited: 28
Chromatin and Epigenetic Dysregulation of Prostate Cancer Development, Progression, and Therapeutic Response
Konsta Kukkonen, Sinja Taavitsainen, Laura Huhtala, et al.
Cancers (2021) Vol. 13, Iss. 13, pp. 3325-3325
Open Access | Times Cited: 27
Konsta Kukkonen, Sinja Taavitsainen, Laura Huhtala, et al.
Cancers (2021) Vol. 13, Iss. 13, pp. 3325-3325
Open Access | Times Cited: 27
Chromatin accessibility regulates chemotherapy-induced dormancy and reactivation
Lujuan Wang, Peng Qiu, Na Yin, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 26, pp. 269-279
Open Access | Times Cited: 17
Lujuan Wang, Peng Qiu, Na Yin, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 26, pp. 269-279
Open Access | Times Cited: 17
CDC20-Mediated hnRNPU Ubiquitination Regulates Chromatin Condensation and Anti-Cancer Drug Response
Cindy Wavelet-Vermuse, Olena Odnokoz, Yifan Xue, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3732-3732
Open Access | Times Cited: 9
Cindy Wavelet-Vermuse, Olena Odnokoz, Yifan Xue, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3732-3732
Open Access | Times Cited: 9
Epigenetic inhibition of CTCF by HN1 promotes dedifferentiation and stemness of anaplastic thyroid cancer
Zongfu Pan, Xixuan Lu, Tong Xu, et al.
Cancer Letters (2023) Vol. 580, pp. 216496-216496
Closed Access | Times Cited: 4
Zongfu Pan, Xixuan Lu, Tong Xu, et al.
Cancer Letters (2023) Vol. 580, pp. 216496-216496
Closed Access | Times Cited: 4
Chromatin accessibility analysis uncovers regulatory element landscape in prostate cancer progression
Joonas Uusi-Mäkelä, Ebrahim Afyounian, Francesco Tabaro, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Closed Access | Times Cited: 8
Joonas Uusi-Mäkelä, Ebrahim Afyounian, Francesco Tabaro, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Closed Access | Times Cited: 8
Job Opening for Nucleosome Mechanic: Flexibility Required
Mary Pitman, Daniël P. Melters, Yamini Dalal
Cells (2020) Vol. 9, Iss. 3, pp. 580-580
Open Access | Times Cited: 7
Mary Pitman, Daniël P. Melters, Yamini Dalal
Cells (2020) Vol. 9, Iss. 3, pp. 580-580
Open Access | Times Cited: 7
p53 expression confers sensitivity to 5‑fluorouracil via distinct chromatin accessibility dynamics in human colorectal cancer
Yang Chul, Moo-Koo Kang, Woong-Jae Jung, et al.
Oncology Letters (2021) Vol. 21, Iss. 3
Open Access | Times Cited: 7
Yang Chul, Moo-Koo Kang, Woong-Jae Jung, et al.
Oncology Letters (2021) Vol. 21, Iss. 3
Open Access | Times Cited: 7
CHD6 promotes broad nucleosome eviction for transcriptional activation in prostate cancer cells
Dongyu Zhao, Min Zhang, Shaodong Huang, et al.
Nucleic Acids Research (2022) Vol. 50, Iss. 21, pp. 12186-12201
Open Access | Times Cited: 5
Dongyu Zhao, Min Zhang, Shaodong Huang, et al.
Nucleic Acids Research (2022) Vol. 50, Iss. 21, pp. 12186-12201
Open Access | Times Cited: 5
Epigenetic Editing in Prostate Cancer: Challenges and Opportunities
Mariana Brütt Pacheco, Vânia Camilo, Rui Henrique, et al.
Epigenetics (2021) Vol. 17, Iss. 5, pp. 564-588
Open Access | Times Cited: 6
Mariana Brütt Pacheco, Vânia Camilo, Rui Henrique, et al.
Epigenetics (2021) Vol. 17, Iss. 5, pp. 564-588
Open Access | Times Cited: 6
In vitro neuroendocrine differentiation of BPH-1 cells under beta2 adrenergic receptor stimulation
Natascha Pigat, Laura Nalleli Garrido Castillo, Coline Lefèvre, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Natascha Pigat, Laura Nalleli Garrido Castillo, Coline Lefèvre, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Understanding the molecular regulators of neuroendocrine prostate cancer
Sreyashi Bhattacharya, Avery Stillahn, Kaitlin Smith, et al.
Advances in cancer research (2024), pp. 403-429
Closed Access
Sreyashi Bhattacharya, Avery Stillahn, Kaitlin Smith, et al.
Advances in cancer research (2024), pp. 403-429
Closed Access
Challenges and Opportunities of Genomic Approaches in Therapeutics Development
Jaimie S. Gray, Moray J. Campbell
Methods in molecular biology (2020), pp. 107-126
Closed Access | Times Cited: 2
Jaimie S. Gray, Moray J. Campbell
Methods in molecular biology (2020), pp. 107-126
Closed Access | Times Cited: 2
Data from BRD9 Is a Critical Regulator of Androgen Receptor Signaling and Prostate Cancer Progression
Aktan Alpsoy, Sagar M. Utturkar, Benjamin C. Carter, et al.
(2023)
Open Access
Aktan Alpsoy, Sagar M. Utturkar, Benjamin C. Carter, et al.
(2023)
Open Access
